Literature DB >> 21299504

Challenging the glucose challenge test.

Jenny Huynh1, Sujiva Ratnaike, Catherine Bartalotta, Michael Permezel, Christine Houlihan.   

Abstract

BACKGROUND: To reduce the number of patients needing oral glucose tolerance test (OGTT), screening options have been considered, balancing patient comfort, cost and risk of missed diagnosis. Australian Diabetes in Pregnancy Society (ADIPS) recommends glucose challenge test (GCT) as screening for gestational diabetes mellitus (GDM), while others suggest fasting plasma glucose (FPG). International Association of Diabetes and Pregnancy Study Group (IADPSG) recently recommended new diagnostic criteria for GDM using one-step OGTT. AIM: (i) To determine how many GDM patients would be missed with GCT/OGTT or FPG/OGTT compared to OGTT alone. (ii) To assess GCT in screening for GDM using new IADPSG criteria.
METHODS: Austin Pathology database was searched from 2005 to 2007; 8486 episodes of GCT and OGTT were found. Test characteristics were determined for: (i) Simulated GCT/OGTT, where the 60-min OGTT value was regarded as equivalent to 60-min GCT value; (ii) Simulated FPG/OGTT, investigating the utility of different FPG values to indicate need for OGTT.
RESULTS: Oral glucose tolerance test (one-step procedure): Of 5473 patients who had OGTT alone, 14% had GDM (ADIPS criteria). Actual GCT/OGTT: Of 2407 GCT, 17.3% were abnormal, with 75% having normal follow-up OGTT. Simulated studies: In the simulated GCT/OGTT, using ADIPS criteria, GCT had a sensitivity of 87%, specificity of 74% and would miss 13% of cases. Although simulated FG/OGTT had similar sensitivity of 82% for FPG ≥4.4 mmol/L, specificity was 42%. Using IADPSG criteria, 19% were diagnosed with GDM, screening GCT had a sensitivity of 83%, specificity of 75% and would miss 17% of cases.
CONCLUSION: Oral glucose tolerance test alone is the best procedure without prior preliminary testing.
© 2010 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology © 2010 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Mesh:

Year:  2010        PMID: 21299504     DOI: 10.1111/j.1479-828X.2010.01247.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  7 in total

1.  Universal Screening for Gestational Diabetes Mellitus (GDM): Mandatory.

Authors:  C N Purandare
Journal:  J Obstet Gynaecol India       Date:  2012-07-17

2.  Early third trimester maternal response to glucose challenge and pregnancy outcome in Chinese women-relationship between upper distribution level and recommended diagnostic criteria.

Authors:  M Y Du; R M Ma; T T-H Lao; Z Chen; H Xiao; Y Q Tian; B L Li; K Liang; L Zhang; M H Yang; J Li; H Li; R Yan; L Geng; W J Qi; H Y Li; J Xu; S Q Hu; G H Liang; J H Yu
Journal:  Eur J Clin Nutr       Date:  2015-01-28       Impact factor: 4.016

3.  Macrosomia in non-gestational diabetes pregnancy: glucose tolerance test characteristics and feto-maternal complications in tropical Asia Pacific Australia.

Authors:  Algenes Aranha; Usman H Malabu; Venkat Vangaveti; Elham Saleh Reda; Yong Mong Tan; Kunwarjit Singh Sangla
Journal:  Asian Pac J Trop Biomed       Date:  2014-06

4.  Cost-effectivity analysis of one-step versus two-step screening for gestational diabetes.

Authors:  Sevki Celen; Yasemin Yildiz; Serkan Kahyaoglu; Oktay Kaymak; Murat Ozel; Hakan Timur; Nuri Danisman
Journal:  Eurasian J Med       Date:  2012-08

5.  Single-Step First Trimester Screening "Sooner the Better".

Authors:  Abha Singh; Avinashi Kujur
Journal:  J Obstet Gynaecol India       Date:  2015-10-16

6.  Effects of resistance exercise on blood glucose level and pregnancy outcome in patients with gestational diabetes mellitus: a randomized controlled trial.

Authors:  Yaping Xie; Huifen Zhao; Meijing Zhao; Huibin Huang; Chunhong Liu; Fengfeng Huang; Jingjing Wu
Journal:  BMJ Open Diabetes Res Care       Date:  2022-04

Review 7.  Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States.

Authors:  Catherine Chamberlain; Bridgette McNamara; Emily D Williams; Daniel Yore; Brian Oldenburg; Jeremy Oats; Sandra Eades
Journal:  Diabetes Metab Res Rev       Date:  2013-05       Impact factor: 4.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.